Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 32 citing Parimon: A risk score for mortality after allogeneic hematopoietic cell transplantation. (0.16 sec) 

Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in …


A Fyles, M Milosevic, M Pintilie, A Syed, W … - Radiotherapy and Oncology, 2006 - Elsevier
Patients ranged in age from 23 to 78 years with a mean of 53 years. The maximum
tumor size ranged from 2 to 10 cm, with a median diameter of 5 cm. FIGO stage
was IB in 28 patients, IIA in 4, IIB in 42 and IIIB in 33 patients. ...
Cited by 28 - Related articles - All 17 versions

Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the …

- ufl.edu [PDF] 
J Tay, A Tinmouth, D Fergusson, L Huebsch, … - Biology of Blood and Marrow Transplantation, 2007 - Elsevier
Hepatic veno-occlusive disease (HVOD) is a serious life-threatening complication
of hematopoietic stem cell transplantation (HSCT). Currently, there is no
optimal therapeutic strategy and preventive measures are ill-defined. ...
Cited by 16 - Related articles - All 10 versions

A prospective cohort study of postoperative complications in the management of perforated …


SS Sharma, MR Mamtani, MS Sharma, H … - BMC surgery, 2006 - biomedcentral.com
In a prospective cohort study of 96 subjects presenting as perforated peptic
ulcer and treated using Graham's omentoplatsy patch or gastrojejunostomy (with
total truncal vagotomy), we assessed the association of clinical predictors ...
Cited by 11 - Related articles - Cached - All 17 versions

Lack of effect of donor–recipient ABO mismatching on outcome following allogeneic …


TR Klumpp, JH Herman, J Ulicny, RVB … - Bone Marrow Transplantation, 2006 - nature.com
Several recently published studies have suggested that patients who undergo ABO
mismatched hematopoietic stem cell transplantation may be at increased risk for
relapse, graft-versus-host disease, transplant-related mortality, and/or ...
Cited by 10 - Related articles - BL Direct - All 4 versions

Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with …

- nih.gov
M Mielcarek, BE Storer, BM Sandmaier, ML … - Biology of Blood and Marrow Transplantation, 2007 - Elsevier
We sought to determine whether patients with hematologic malignancies treated by
nonmyeloablative hematopoietic cell transplantation (HCT) at a single
institution between December 1997 and June 2006 had worse outcomes with ...
Cited by 9 - Related articles - All 8 versions

Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative …

- hematologylibrary.org
JW Chien, MJ Boeckh, JA Hansen, JG Clark - Blood, 2008 - bloodjournal.hematologylibrary.org
Lipopolysaccharide binding protein (LBP) function is dependent on circulating
LBP levels. Disturbance of LBP transcription regulation may influence the risk
for clinical events. In a nested case-control study using a single ...
Cited by 8 - Related articles - BL Direct - All 3 versions

A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing …

- nih.gov
P Armand, HT Kim, CS Cutler, VT Ho, J Koreth, … - Biology of Blood and Marrow Transplantation, 2007 - Elsevier
Allogeneic hematopoietic stem cell transplantation (SCT) has the potential to
cure patients with acute leukemia or myelodysplastic syndromes (MDS), but a
number of prognostic factors can influence the outcome of transplantation. ...
Cited by 8 - Related articles - All 9 versions

Risk assessment in haematopoietic stem cell transplantation


A Gratwohl - Best Practice & Research Clinical Haematology, 2007 - Elsevier
The conflict in decision-making becomes apparent when long-term results of a
large heterogeneous series are considered: roughly 50% of all patients are alive
at 5 years, while 50% have died (Figure 1). 3 For a patient, outcome after ...
Cited by 7 - Related articles - All 16 versions

[CITATION] Outcomes research in hematopoietic cell transplantation


SJ Lee - Thomas' hematopoietic cell transplantation. 3rd ed. …, 2004
Cited by 6 - Related articles - All 2 versions

Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in …


W Ingram, S Devereux, EP Das-Gupta, NH … - British Journal of Haematology, 2008 - interscience.wiley.com
The role of haematopoietic stem cell transplantation (HSCT) in relapsed
follicular lymphoma remains controversial. This study analysed 126 patients with
relapsed, advanced stage follicular lymphoma who received BEAM (BCNU ...
Cited by 6 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google